Age, Biography and Wiki

Alex Azar (Alex Michael Azar II) was born on 17 June, 1967 in Johnstown, Pennsylvania, U.S., is an Alex Michael Azar II is attorney, businessman, lobbyist. Discover Alex Azar's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is he in this year and how he spends money? Also learn how he earned most of networth at the age of 56 years old?

Popular As Alex Michael Azar II
Occupation Politician attorney businessman lobbyist former pharmaceutical executive
Age 56 years old
Zodiac Sign Gemini
Born 17 June 1967
Birthday 17 June
Birthplace Johnstown, Pennsylvania, U.S.
Nationality United States

We recommend you to check the complete list of Famous People born on 17 June. He is a member of famous Politician with the age 56 years old group.

Alex Azar Height, Weight & Measurements

At 56 years old, Alex Azar height not available right now. We will update Alex Azar's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.

Physical Status
Height Not Available
Weight Not Available
Body Measurements Not Available
Eye Color Not Available
Hair Color Not Available

Who Is Alex Azar's Wife?

His wife is Jennifer Reist

Family
Parents Not Available
Wife Jennifer Reist
Sibling Not Available
Children 2

Alex Azar Net Worth

His net worth has been growing significantly in 2023-2024. So, how much is Alex Azar worth at the age of 56 years old? Alex Azar’s income source is mostly from being a successful Politician. He is from United States. We have estimated Alex Azar's net worth, money, salary, income, and assets.

Net Worth in 2024 $1 Million - $5 Million
Salary in 2024 Under Review
Net Worth in 2023 Pending
Salary in 2023 Under Review
House Not Available
Cars Not Available
Source of Income Politician

Alex Azar Social Network

Instagram
Linkedin
Twitter
Facebook
Wikipedia Alex Azar Wikipedia
Imdb

Timeline

1967

Alex Michael Azar II (born June 17, 1967) is an American attorney, businessman, lobbyist, and former pharmaceutical executive who served as the U.S. Secretary of Health and Human Services from 2018 to 2021.

Azar was born on June 17, 1967, in Johnstown, Pennsylvania, the son of Lynda (Zarisky) and Alex Michael Azar Sr.

His father is a retired ophthalmologist who practiced ophthalmology in Salisbury, Maryland, for more than 30 years, and taught at Johns Hopkins Hospital.

His grandfather emigrated from Lebanon in the early 20th century.

The family originates from Amioun.

1985

Azar attended Parkside High School in Salisbury, Maryland, where he graduated in 1985.

1988

He received a B.A. degree summa cum laude in government and economics from Dartmouth College in 1988.

He belonged to the Kappa Kappa Kappa fraternity.

1991

He earned a J.D. degree from Yale Law School in 1991, where he served as a member of the executive committee of the Yale Law Journal.

After law school, from 1991 to 1992, Azar served as a law clerk for Judge Alex Kozinski of the United States Court of Appeals for the Ninth Circuit.

Azar left after six weeks, and was replaced in Kozinski's chambers by Brett Kavanaugh.

Azar subsequently clerked for the remainder of the term for Judge J. Michael Luttig of the United States Court of Appeals for the Fourth Circuit.

1992

From 1992 to 1993, he served as a law clerk for Associate Justice Antonin Scalia of the United States Supreme Court.

1994

From 1994 to 1996, he served as an associate independent counsel for Ken Starr in the United States Office of the Independent Counsel, where he worked on the first two years of the investigation into the Whitewater controversy.

At the time of Azar's appointment, he was working as an associate in Starr's law firm.

1996

Between 1996 and 2001, Azar worked for Wiley Rein, a Washington, D.C., law firm, where he achieved partner status.

2001

Azar served as general counsel of the U.S. Department of Health and Human Resources (HHS) from 2001 to 2005.

On August 3, 2001, Azar was confirmed as general counsel of the United States Department of Health and Human Services.

George W. Bush's first HHS secretary, Tommy Thompson, said Azar played an important role in responding to the 2001 anthrax attacks, ensuring there was a vaccine ready for smallpox, and dealing with outbreaks of SARS and influenza.

2005

On July 22, 2005, he was confirmed as the deputy secretary of Health and Human Services; he served in that capacity until his January 2007 resignation.

On July 22, 2005, Azar was confirmed as the deputy secretary of Health and Human Services.

He was twice confirmed unanimously by the United States Senate.

2007

Azar resigned in January 2007.

In June 2007, Azar was hired by Eli Lilly and Company chief executive officer Sidney Taurel to be the company's top lobbyist and spokesman as its senior vice president of corporate affairs and communications.

2008

Azar left the position after the 2008 United States presidential election was won by Democratic Party candidate Barack Obama and the corporation wanted to replace Azar with a Democrat in that role.

2009

In April 2009, Azar became vice president of Lilly's U.S. Managed Healthcare Services organization and its Puerto Rico affiliate.

In 2009, the company paid $1.415 billion to settle criminal charges regarding its promotion of antipsychotic drug Zyprexa (olanzapine) for off-label uses between 1999 and 2005.

2012

From 2012 to 2017, Azar was president of the U.S. division of Eli Lilly and Company, a major drug company, and a member of the board of directors of the Biotechnology Innovation Organization, a large pharmaceutical trade association.

In 2021, he was appointed a senior executive in residence at the Miami Herbert Business School at the University of Miami.

Effective January 1, 2012, Azar became president of Lilly USA, LLC, the largest division of Eli Lilly and Company, and was responsible for the company's entire operations in the United States.

Prices for drugs rose substantially under Azar's leadership, including the tripling of the cost of the company's top-selling insulin drug.

Also under Azar's watch, Eli Lilly was one of three companies accused in a class-action lawsuit of exploiting the drug pricing system to increase profits for insulin.

Eli Lilly was also fined in Mexico for colluding on the price of insulin.

In connection with the position, Azar served on the board of directors of the Biotechnology Innovation Organization, a pharmaceutical lobby.

2017

Azar was nominated to his post by President Donald Trump on November 13, 2017, and confirmed by the United States Senate on January 24, 2018.

Working under Secretary Mike Leavitt, Deputy Azar supervised the operation of HHS, which would grow to an annual budget of over $1 trillion by 2017 when he was appointed secretary.

Azar led the development and approval of HHS regulations, led U.S. government efforts to encourage worldwide pharmaceutical and medical device innovation, and was in charge of the HHS response to an initiative implemented by President George W. Bush to improve government performance.

In January 2017, Azar resigned from Eli Lilly "to pursue other career opportunities" as a result of a company reorganization.

He also resigned from the board of directors of the Biotechnology Innovation Organization.

2020

He was also chairman of the White House Coronavirus Task Force from its inception in January 2020 to February 2020, when he was replaced by Vice President Mike Pence.